Key Takeaways
- In 2021, the U.S. recorded 80,411 opioid-involved overdose deaths, a 22% increase from 2020.
- Synthetic opioids other than methadone (primarily fentanyl) were involved in 71,238 overdose deaths in 2021.
- Heroin-involved overdose deaths totaled 9,273 in 2021, down from previous years.
- U.S. prescribers wrote 191.5 opioid prescriptions per 100 people in 2017.
- Opioid prescribing rates declined 44% from 2011 peak to 2020.
- In 2022, 41.9 million people aged 12+ misused prescription opioids.
- Opioids involved in 49% of ED visits for misuse 2019.
- Adults aged 35-44 had highest opioid overdose ED visit rate: 40.2 per 100,000 in 2021.
- Non-Hispanic Black persons: opioid death rate 31.5 per 100,000 in 2021.
- In 2022, opioid epidemic cost U.S. economy $1.02 trillion.
- Healthcare costs for opioid use disorder: $78.4 billion annually pre-2020.
- Lost productivity from opioid deaths: $504 billion 2015-2020.
- Only 1 in 5 with OUD received treatment in 2021.
- Buprenorphine prescriptions increased 128% from 2013-2022.
- Naloxone distribution saved 26,000 lives 1996-2014.
Fentanyl drives a devastating opioid crisis with soaring overdose deaths across America.
Demographic Impacts
- Opioids involved in 49% of ED visits for misuse 2019.
- Adults aged 35-44 had highest opioid overdose ED visit rate: 40.2 per 100,000 in 2021.
- Non-Hispanic Black persons: opioid death rate 31.5 per 100,000 in 2021.
- Rural residents 25% more likely to overdose than urban.
- Males accounted for 69% of opioid overdose deaths in 2021.
- American Indian/Alaska Native: highest opioid hospitalization rate 2018-2021.
- Ages 25-44: 56% of opioid deaths in 2021.
- Women: opioid misuse rate 0.9% vs men 1.1% in 2021.
- Appalachia: 32% of population but 20% of opioid deaths 2011-2015.
- Hispanic opioid death rate: 17.6 per 100,000 in 2021.
- Veterans: 20.7 opioid deaths per 100,000 in 2020.
- Pregnant women opioid prescriptions: 7% in 2020.
- Non-rural areas saw 30% rise in opioid deaths among Black individuals 2015-2019.
- Ages 12-17: 2.4% misused opioids past year 2021.
- Native Hawaiian/Pacific Islander: overdose rate 30.3 per 100,000.
- Low-income (<$20k) households: 2x opioid misuse rate.
- Southern states: 40% of national opioid prescriptions but higher misuse.
- Males 25-34: peak overdose death rate 70+ per 100,000.
- Black females opioid deaths tripled 2012-2021.
- Adults 65+: stable 10 per 100,000 death rate.
- Urban opioid hospitalization rates 1.5x rural post-2019.
- Less educated (HS or less): 2.5x higher OUD risk.
- Midwestern states opioid deaths disproportionately white males.
- Youth 12-20: ED visits for opioids fell 60% 2016-2020.
- Disability-linked households: 3x overdose rate.
- Asian Americans lowest misuse at 0.4% in 2021.
- Construction workers: highest OUD prevalence 5-10%.
- Females 85+: highest female death rate per capita.
- Tribal lands: opioid deaths 4x national average.
- Uninsured: 2x ED visits for opioid overdose.
- Baby boomers (55-73): rising misuse from prescriptions.
- Black males 25-44: fastest rising death rate 2015-2021.
- Farmers/ag workers: 35% higher overdose risk.
- LGBTQ+ youth: 20% higher misuse rates.
- Divorced/widowed: 1.8x OUD odds.
- Northeast urban Black communities: 50% death increase 2019-2021.
- Ages 45-54 males: 40.1 death rate per 100,000.
- Medicaid enrollees: 25% of opioid deaths despite 15% population.
- Native-born citizens higher misuse than immigrants.
- Military personnel past service: 1.5x OUD risk.
Demographic Impacts Interpretation
Economic Burden
- In 2022, opioid epidemic cost U.S. economy $1.02 trillion.
- Healthcare costs for opioid use disorder: $78.4 billion annually pre-2020.
- Lost productivity from opioid deaths: $504 billion 2015-2020.
- Criminal justice costs: $42 billion yearly from opioid misuse.
- From 2015-2019, opioid crisis cost states $70 billion in direct spending.
- Worker absenteeism due to opioids: 3.7 million lost workdays 2017.
- Opioid-related hospitalizations cost $15.7 billion in 2012.
- Neonatal abstinence syndrome treatment: $2.6 billion yearly.
- In 2017, total economic burden $1.02 trillion including 47,000 deaths.
- Family members lost $13.5 billion in household earnings 2019.
- Medicare opioid spending: $4.5 billion on misuse 2019.
- Employer costs for opioid-dependent workers: $11,000 extra per employee yearly.
- 2020 opioid crisis added $100 billion to healthcare spending.
- Lost tax revenue from opioid deaths: $12.4 billion annually.
- Child welfare costs: $8.2 billion yearly from opioid-affected families.
- In WV, opioid costs 7.5% of state GDP in 2017.
- Emergency services for overdoses: $3.6 billion in 2018.
- Disability claims from OUD: 1 million+, costing $20 billion SSA.
- Opioid makers settled lawsuits for $50+ billion 2019-2023.
- Reduced labor force participation: 1.1 million workers sidelined 2019.
- Treatment costs: $35 billion annually for OUD services.
- In 2021, opioid-related productivity losses $665 billion.
- Foster care placements doubled to 300,000 due to opioids, costing $10B.
- Hospitals wrote off $1.2 billion uncompensated opioid care 2017.
- Small businesses lost $15 billion in revenue from employee OUD 2018.
- Global opioid economic cost: $1 trillion yearly including U.S.
- Insurance premiums rose 7% due to opioid claims 2015-2020.
- Public assistance for OUD families: $25 billion SNAP/Medicaid.
- Opioid tourism in Canada cost provinces $500 million healthcare.
- U.S. GDP reduction 0.8% attributable to opioids 2017.
- Suicide-related opioid costs: $10 billion yearly.
- Law enforcement seizures costs $2 billion annually.
- Education impacts: 1.5 million kids miss school yearly, $5B lost.
- In 2019, per-death economic cost $1.02 million.
- MAT treatment ROI: $36,000 saved per patient yearly.
- Homelessness linked to opioids costs $4 billion sheltering.
- Tourism decline in hard-hit areas: 10% revenue drop.
- 2023 projected costs exceed $1.5 trillion with inflation.
Economic Burden Interpretation
Intervention and Treatment
- Only 1 in 5 with OUD received treatment in 2021.
- Buprenorphine prescriptions increased 128% from 2013-2022.
- Naloxone distribution saved 26,000 lives 1996-2014.
- Medications for OUD (MOUD) used by 23% of those in treatment 2021.
- SAMHSA treatment facilities for opioids: 17,000+ in 2022.
- Overdose deaths declined 20% in communities with high naloxone access.
- Methadone patients retained 70% at 6 months vs 40% non-medicated.
- PDMP implementation reduced opioid overdoses 10-15%.
- 2.3 million received substance use treatment, 1.4M for opioids 2021.
- Fentanyl test strips detected 90% of cases in pilot programs.
- Syringe services programs prevented 10,000+ HIV cases.
- Buprenorphine waiver holders increased to 108,000 by 2023.
- 48 states have good Samaritan laws protecting naloxone users.
- Residential treatment completion: 55% for opioid patients.
- Telehealth MAT visits surged 150% during pandemic.
- Xylazine-opioid mixes prompted new reversal agents trials.
- Harm reduction funding: $1.1 billion in 2022 ARP.
- Contingency management boosted abstinence 50% in trials.
- Pregnant women in MAT: 70% better birth outcomes.
- 911 Good Samaritan laws in 35 states reduced overdose deaths 11%.
- Peer recovery coaching improved retention 40%.
- Vivitrol (naltrexone) use rose 20% post-approval expansions.
- Community-based naloxone: 1 dose reverses 80% overdoses if prompt.
- OTPs (opioid treatment programs) served 500,000 patients 2022.
- Criminal justice diversion programs retained 60% in treatment.
- Psychedelic-assisted therapy trials for OUD phase 2 success 70%.
- Medicaid expansion states saw 25% more OUD treatment access.
- Sober living homes: 60% abstinence at 1 year.
- CDC guideline adherence reduced high-risk prescribing 50%.
- Fentanyl vaccine in animal trials prevented 85% overdose.
- Integrated care models for OUD+MH: 75% retention.
- Rural MAT access improved 300% with hub-spoke models.
- Nalmefene as alternative reversal agent approved EU, trials U.S.
Intervention and Treatment Interpretation
Mortality Statistics
- In 2021, the U.S. recorded 80,411 opioid-involved overdose deaths, a 22% increase from 2020.
- Synthetic opioids other than methadone (primarily fentanyl) were involved in 71,238 overdose deaths in 2021.
- Heroin-involved overdose deaths totaled 9,273 in 2021, down from previous years.
- Natural and semisynthetic opioids caused 15,492 deaths in 2021.
- Methadone was implicated in 5,520 overdose deaths in 2021.
- From 1999 to 2021, nearly 645,000 people died from an opioid-involved overdose in the U.S.
- Opioid-involved death rates rose from 6.5 per 100,000 in 1999 to 32.3 per 100,000 in 2021.
- In 2022 provisional data, opioid deaths reached 81,806.
- Age-adjusted opioid overdose death rate was highest among adults aged 35-44 at 52.3 per 100,000 in 2021.
- Males had an opioid death rate of 45.5 per 100,000 vs. 20.0 for females in 2021.
- West Virginia had the highest opioid death rate at 81.4 per 100,000 in 2021.
- In 2019, opioid overdoses killed 49,860 people, 70.8% of all drug overdose deaths.
- Fentanyl analogs contributed to over 36,000 deaths in 2021.
- Neonatal abstinence syndrome cases linked to opioids affected 7 per 1,000 hospital births in 2017.
- Opioid deaths increased 309% from 2010 to 2020.
- In 2020, 91,799 drug overdose deaths occurred, with 75% opioid-related.
- Black non-Hispanic persons saw opioid death rates rise 44% from 2019-2020.
- Provisional 2023 data shows 74,702 opioid deaths.
- From May 2020 to April 2021, opioid deaths surged 37.7%.
- In Appalachia, opioid mortality rate was 50.2 per 100,000 from 2011-2015.
- In 2021, 24,486 deaths involved both opioids and stimulants.
- Opioid death rate for American Indian/Alaska Native was 56.6 per 100,000 in 2021.
- From 2015-2019, synthetic opioid deaths increased 345%.
- In Canada, opioid toxicity deaths reached 7,550 in 2022.
- UK opioid-related deaths were 4,907 in 2022, mostly methadone.
- Australia recorded 2,200 opioid deaths in 2021.
- In 2017, U.S. opioid prescriptions peaked but deaths continued rising due to illicit fentanyl.
- Emergency department visits for opioid overdoses doubled from 2016-2021 in some regions.
- 2021 saw 13,162 deaths from prescription opioid overdoses.
- Opioid mortality among pregnant women rose 4-fold from 2007-2016.
- In 2021, 14 states had opioid death rates over 40 per 100,000.
- In 2019, 50,042 Americans died from opioid overdoses.
- High-dose opioid prescribing linked to 1 in 5 overdose deaths.
- In 2020, opioids were involved in 68.5% of all overdose deaths.
- From 1999-2020, opioid deaths totaled 500,000+.
- In 2022, fentanyl was in 68% of overdose deaths per toxicology.
- U.S. opioid death rate 3x higher than EU average in 2019.
- In 2018, 46,802 opioid deaths occurred.
- Rural opioid death rates 50% higher than urban in 2017.
- 2021 cocaine-opioid deaths: 24,486.
- Opioid deaths in youth (15-24) rose 94% from 1999-2008.
- In 2021, the average annual opioid death rate increase was 14% over prior decade.
- New Mexico opioid death rate: 48.0 per 100,000 in 2021.
- In 2016, 42,249 opioid deaths marked record high then.
- Fentanyl death rate: 23.8 per 100,000 in 2021.
- Opioid deaths fell 8.6% in late 2023 provisional data.
- In 2020, 93,000+ total overdose deaths, 75% opioids.
- Black opioid death rate surpassed white in 2020 at 28.4 per 100,000.
- In 2015, prescription opioid deaths peaked at 15,691.
- Heroin deaths peaked at 15,469 in 2016.
- In Q1 2023, opioid deaths declined 13% from prior year.
Mortality Statistics Interpretation
Prescription Rates
- U.S. prescribers wrote 191.5 opioid prescriptions per 100 people in 2017.
- Opioid prescribing rates declined 44% from 2011 peak to 2020.
- In 2022, 41.9 million people aged 12+ misused prescription opioids.
- From 2006-2012, opioid prescriptions tripled to 259 million.
- High-dose opioid prescriptions (>90 MME) dropped 62% from 2010-2019.
- In 2012, enough opioids prescribed for every American to have 5-week supply.
- Opioid prescribing rate: 42.0 per 100 in 2021, down from 78.5 in 2012.
- Oxycodone prescriptions: 34 million in 2022.
- Hydrocodone prescriptions declined 57% from 2013-2020.
- In 2020, 9.3% of adults filled opioid prescription.
- Medicare Part D opioid prescriptions: 145 million in 2021.
- From 2013-2018, opioid dispensing rates fell 35.5%.
- In Appalachia, prescribing rates 50% higher than national average in 2017.
- 12.5 million Americans misused prescription opioids in 2021.
- Opioid prescriptions per capita highest in Alabama: 101.7 in 2015.
- Post-2010 CDC guidelines, prescribing dropped 51% by 2020.
- In 2019, 10.1 million misused prescription pain relievers.
- Long-acting opioid prescriptions fell 79% from 2010-2020.
- Veteran opioid prescribing: 25% reduction 2012-2020.
- In 2022, 2.7% of U.S. population had opioid use disorder.
- Opioid sales quadrupled 1999-2010 to 219,000 lbs morphine equivalents.
- Pediatric opioid prescriptions declined 50% 2012-2021.
- Cancer patients opioid prescribing stable at 20-30% higher than non-cancer.
- In 2017, 18.0% of surgical patients received opioid prescription post-op.
- Telehealth opioid prescriptions surged 52% during COVID-19.
- Rural prescribing rates 23% higher than urban in 2019.
- Immediate-release opioids 80% of prescriptions but 30% of overdose deaths.
- From 2007-2017, opioid prescriptions to adolescents fell 40%.
- In 2021, average opioid prescription duration: 8.8 days.
- Opioid naive patients: 70% of new prescriptions under 3 days.
- States with PDMPs saw 10-25% drop in opioid volume post-implementation.
- In 2020, 16.6 million opioid prescriptions in emergency departments.
- Dentists prescribed 8% of opioids in 2016, down 30% since 2012.
- Opioid prescribing for chronic pain fell to 12% of visits by 2020.
- In 2021, White non-Hispanics had highest prescription rates at 10.4%.
- Opioid dispensing to ages 65+: 12.4% in 2020.
- In 2019, 2.0 million adolescents misused prescription opioids.
- High prescribing states like WV: 81.4 scripts per 100 in 2015.
- Post-surgery opioid fills: 80% within 7 days, 2012-2017.
- In 2022, buprenorphine prescriptions rose 22% to treat OUD.
- Opioid prescriptions in Medicaid: 15% of enrollees in 2021.
- From 2012-2021, opioid Rx per capita halved in most states.
- In 2021, 17.1% of U.S. adults experienced pain most days, many prescribed opioids.
- Emergency opioid prescriptions declined 29% 2012-2017.
- In 2020, 5.6 million adults misused prescription pain relievers.
- Rural Medicare opioid Rx rate: 8.8% vs urban 7.1% in 2019.
- Ages 25-44 had highest misuse rates at 1.4% in 2021.
- In 2016, 11.5 million misused prescription opioids past year.
- Opioid prescribing guidelines reduced doses by 60% in VA system.
- In 2022, 7.5% of pregnant women filled opioid prescriptions.
- Non-Hispanic White adults: 8.5% opioid prescription rate in 2020.
Prescription Rates Interpretation
Sources & References
- Reference 1CDCcdc.govVisit source
- Reference 2NIDAnida.nih.govVisit source
- Reference 3KFFkff.orgVisit source
- Reference 4HEALTH-INFOBASEhealth-infobase.canada.caVisit source
- Reference 5ONSons.gov.ukVisit source
- Reference 6AIHWaihw.gov.auVisit source
- Reference 7ECDCecdc.europa.euVisit source
- Reference 8SAMHSAsamhsa.govVisit source
- Reference 9DEAdea.govVisit source
- Reference 10CMScms.govVisit source
- Reference 11AMA-ASSNama-assn.orgVisit source
- Reference 12VAva.govVisit source
- Reference 13JAMANETWORKjamanetwork.comVisit source
- Reference 14MEDICAIDmedicaid.govVisit source
- Reference 15ASPEaspe.hhs.govVisit source
- Reference 16WHITEHOUSEwhitehouse.govVisit source
- Reference 17PEWTRUSTSpewtrusts.orgVisit source
- Reference 18NCBIncbi.nlm.nih.govVisit source
- Reference 19AAMCaamc.orgVisit source
- Reference 20SHRMshrm.orgVisit source
- Reference 21HEALTHAFFAIRShealthaffairs.orgVisit source
- Reference 22TAXFOUNDATIONtaxfoundation.orgVisit source
- Reference 23BROOKINGSbrookings.eduVisit source
- Reference 24SSAssa.govVisit source
- Reference 25JUSTICEjustice.govVisit source






